Arthur David J.'s Form 4 filing
Decoy Therapeutics Inc. (DCOY) · filed May 31, 2022
- Accession no.
- 0001615219-22-000087
- Filed
- May 31, 2022, 5:17 PM ET
- Trade date
- May 26, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market purchases total $7.98K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arthur David J.CIK 0001769331 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 26, 2022 | Common Stock | PPurchaseAcquired | +3,400 | $0.18 | +$612 | 263,074 | Direct | |
| May 26, 2022 | Common Stock | PPurchaseAcquired | +18,600 | $0.182 | +$3,385.2 | 281,674 | Direct | |
| May 26, 2022 | Common Stock | PPurchaseAcquired | +708 | $0.18 | +$127.44 | 282,382 | Indirect | |
| May 26, 2022 | Common Stock | PPurchaseAcquired | +10,392 | $0.1799 | +$1,869.52 | 292,774 | Indirect | |
| May 26, 2022 | Common Stock | PPurchaseAcquired | +10,800 | $0.1843 | +$1,990.44 | 303,574 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.